| Product NDC: | 0338-0351 |
| Proprietary Name: | Osmitrol |
| Non Proprietary Name: | Mannitol |
| Active Ingredient(s): | 5 g/100mL & nbsp; Mannitol |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0338-0351 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA013684 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19640608 |
| Package NDC: | 0338-0351-04 |
| Package Description: | 1000 mL in 1 BAG (0338-0351-04) |
| NDC Code | 0338-0351-04 |
| Proprietary Name | Osmitrol |
| Package Description | 1000 mL in 1 BAG (0338-0351-04) |
| Product NDC | 0338-0351 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mannitol |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19640608 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | MANNITOL |
| Strength Number | 5 |
| Strength Unit | g/100mL |
| Pharmaceutical Classes | Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC] |